Abatement of potent p2y12 antagonist-based dual antiplatelet therapy after coronary intervention: a network meta-analysis of randomized controlled trials

HIGHLIGHTS

  • who: Oumaima El Alaoui El Abdallaoui from the Agostino Gemelli University Polyclinic (IRCCS), Italy have published the paper: Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials, in the Journal: (JOURNAL)
  • what: The authors aimed to perform a systematic review and network meta-analysis of the impact of DAPT abatement strategies in patients with PCI.
  • how: The authors calculated the risk ratio (RR) and its standard error using a frequentist approach to construct an NMA model accounting for the correlated treatment effects . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?